Literature DB >> 22706481

Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2.

M Giagnacovo1, M Malatesta, R Cardani, G Meola, C Pellicciari.   

Abstract

Myotonic dystrophies (DM) are genetically based neuromuscular disorders characterized by the accumulation of mutant transcripts into peculiar intranuclear foci, where different splicing factors (among which the alternative splicing regulator muscleblind-like 1 protein, MBNL1) are ectopically sequestered. The aim of the present investigation was to describe the dynamics of the DM-specific intranuclear foci in interphase nuclei and during mitosis, as well as after the exit from the cell cycle. Primary cultures of skin fibroblasts from DM2 patients were used, as a model system to reproduce in vitro, as accurately as possible, the in vivo conditions. Cycling and resting fibroblasts were investigated by immunocytochemical and morphometric techniques, and the relative amounts of MBNL1 were also estimated by western blotting. MBNL1-containing foci were exclusively found in the nucleus during most of the interphase, while being observed in the cytoplasm during mitosis when they never associate with the chromosomes; the foci remained in the cytoplasm at cytodieresis, and underwent disassembly in early G1 to be reformed in the nucleus at each cell cycle. After fibroblasts had stopped dividing in late-passage cultures, the nuclear foci were observed to progressively increase in size. Interestingly, measurements on muscle biopsies taken from the same DM2 patients at different ages demonstrated that, in the nuclei of myofibers, the MBNL1-containing foci become larger with increasing patient's age. As a whole, these results suggest that in non-dividing cells of DM2 patients the sequestration in the nuclear foci of factors needed for RNA processing would be continuous and progressive, eventually leading to the onset (and the worsening with time) of the pathological traits. This is consistent with the evidence that in DM patients the most affected organs or tissues are those where non-renewing cells are mainly present, i.e., the central nervous system, heart and skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706481     DOI: 10.1007/s00418-012-0984-6

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  46 in total

1.  Developmental and cell cycle regulation of the Drosophila histone locus body.

Authors:  Anne E White; Michelle E Leslie; Brian R Calvi; William F Marzluff; Robert J Duronio
Journal:  Mol Biol Cell       Date:  2007-04-18       Impact factor: 4.138

2.  Periodic expression of Sm proteins parallels formation of nuclear Cajal bodies and cytoplasmic snRNP-rich bodies.

Authors:  Dariusz J Smoliński; Bogdan Wróbel; Anna Noble; Agnieszka Zienkiewicz; Alicja Górska-Brylass
Journal:  Histochem Cell Biol       Date:  2011-09-09       Impact factor: 4.304

Review 3.  Cell aging in vivo and in vitro.

Authors:  H Rubin
Journal:  Mech Ageing Dev       Date:  1997-10       Impact factor: 5.432

4.  Nuclear bodies are usual constituents in tissues of hibernating dormice.

Authors:  M Malatesta; A Cardinali; S Battistelli; C Zancanaro; T E Martin; S Fakan; G Gazzanelli
Journal:  Anat Rec       Date:  1999-03

5.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

6.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

7.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

8.  Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.

Authors:  Ian Holt; Virginie Jacquemin; Majid Fardaei; Caroline A Sewry; Gillian S Butler-Browne; Denis Furling; J David Brook; Glenn E Morris
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

9.  Pentamidine reverses the splicing defects associated with myotonic dystrophy.

Authors:  M Bryan Warf; Masayuki Nakamori; Catherine M Matthys; Charles A Thornton; J Andrew Berglund
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-12       Impact factor: 11.205

10.  Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland.

Authors:  Tiina Suominen; Linda L Bachinski; Satu Auvinen; Peter Hackman; Keith A Baggerly; Corrado Angelini; Leena Peltonen; Ralf Krahe; Bjarne Udd
Journal:  Eur J Hum Genet       Date:  2011-03-02       Impact factor: 4.246

View more
  12 in total

Review 1.  The Histochemistry and Cell Biology omnium-gatherum: the year 2015 in review.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2016-02-15       Impact factor: 4.304

Review 2.  The Histochemistry and Cell Biology compendium: a review of 2012.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2013-05-12       Impact factor: 4.304

3.  Dynamic changes of nuclear RNA foci in proliferating DM1 cells.

Authors:  Guangbin Xia; Tetsuo Ashizawa
Journal:  Histochem Cell Biol       Date:  2015-02-26       Impact factor: 4.304

Review 4.  RNA toxicity and foci formation in microsatellite expansion diseases.

Authors:  Nan Zhang; Tetsuo Ashizawa
Journal:  Curr Opin Genet Dev       Date:  2017-02-14       Impact factor: 5.578

Review 5.  Recent advances in myotonic dystrophy type 2.

Authors:  Christina M Ulane; Sarah Teed; Jacinda Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 6.  Skeletal muscle features in myotonic dystrophy and sarcopenia: do similar nuclear mechanisms lead to skeletal muscle wasting?

Authors:  M Malatesta
Journal:  Eur J Histochem       Date:  2012-08-10       Impact factor: 3.188

7.  Muscleblind-like1 undergoes ectopic relocation in the nuclei of skeletal muscles in myotonic dystrophy and sarcopenia.

Authors:  M Malatesta; M Giagnacovo; M Costanzo; B Cisterna; R Cardani; G Meola
Journal:  Eur J Histochem       Date:  2013-04-22       Impact factor: 3.188

Review 8.  RNA Transcription and Maturation in Skeletal Muscle Cells are Similarly Impaired in Myotonic Dystrophy and Sarcopenia: The Ultrastructural Evidence.

Authors:  Manuela Malatesta; Rosanna Cardani; Carlo Pellicciari; Giovanni Meola
Journal:  Front Aging Neurosci       Date:  2014-07-30       Impact factor: 5.750

9.  Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds.

Authors:  Ludovic Arandel; Micaela Polay Espinoza; Magdalena Matloka; Audrey Bazinet; Damily De Dea Diniz; Naïra Naouar; Frédérique Rau; Arnaud Jollet; Frédérique Edom-Vovard; Kamel Mamchaoui; Mark Tarnopolsky; Jack Puymirat; Christophe Battail; Anne Boland; Jean-Francois Deleuze; Vincent Mouly; Arnaud F Klein; Denis Furling
Journal:  Dis Model Mech       Date:  2017-02-10       Impact factor: 5.758

Review 10.  Muscle wasting in myotonic dystrophies: a model of premature aging.

Authors:  Alba Judith Mateos-Aierdi; Maria Goicoechea; Ana Aiastui; Roberto Fernández-Torrón; Mikel Garcia-Puga; Ander Matheu; Adolfo López de Munain
Journal:  Front Aging Neurosci       Date:  2015-07-09       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.